NEW YORK, July 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Hims & Hers Health, Inc. investors who were adversely affected by alleged securities fraud between April 29, 2025 and June 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/ps ...

Group 1 - The healthcare industry is currently viewed positively due to its essential nature and benefits from technological innovations such as AI, genomics, and new solutions for managing chronic diseases [1] - Despite facing challenges like increasing costs and regulatory risks, the outlook for the healthcare sector remains optimistic [1] Group 2 - The analyst has a strong background in finance, with expertise in corporate finance, M&A, and investment analysis, particularly in real estate, renewable energy, and equity markets [2] - The focus is on financial modeling, valuation, and qualitative analysis, with practical experience in private equity and asset management [2]

Core Viewpoint - Berger Montague is investigating potential securities fraud claims against Hims & Hers Health Inc. for making false or misleading statements to investors during the Class Period from April 29, 2025, to June 22, 2025 [1][2] Securities Fraud Investigation Details - On June 23, 2025, Hims & Hers shares fell over 34% after Novo Nordisk terminated its partnership due to unauthorized marketing and sale of compounded semaglutide drugs [2] - A complaint has been filed alleging material misstatements and omissions in violation of federal securities laws [2] Deadline to Act - Investors have until August 25, 2025, to seek appointment as lead plaintiff in the class action lawsuit [3] - Lead plaintiffs will help direct the case and advocate on behalf of other harmed investors [3]

Healthcare & Surgical Procedures - The field of transplant surgery has achieved a success rate of nearly 100% due to decades of innovation and extensive training [1] - Kidney failure is a prevalent condition, affecting approximately one in seven individuals [1] - In the US, around 2 million Americans could potentially benefit from a kidney transplant, with 100,000 currently on the waiting list [1] - The standard operating room temperature is maintained at a cold 65-67 degrees Fahrenheit [1] Patient-Centric Care & Motivation - Understanding a patient's personal reasons for seeking a transplant is crucial for providing holistic care [1][2][3] - Patients' motivations for undergoing transplants often revolve around four key categories: friends and family, experiencing the world through travel, purpose through work, and faith [15] - Patients facing life-threatening illnesses offer unique perspectives on the reasons to live [15] Surgical Team Dynamics & Purpose - The surgical team's morale and focus can be significantly enhanced by recognizing the patient's personal goals [6] - The ability to find purpose in one's work is a privilege that may not be fully appreciated until it is threatened [16] - Reflecting on one's reasons for living is a valuable exercise for individuals in various roles, including coaches, parents, business owners, and leaders [17]

Summary of Key Points from the Conference Call Industry Overview - The report focuses on the mutual fund (MF) sector in China, particularly analyzing the southbound flow of investments and movements of the "national team" in Q225 [2][4]. Core Insights and Arguments 1. **Sector Position Changes**: In Q225, mutual funds increased their positions in banks, telecom, and non-bank financials by 1.6 percentage points each, and 0.8 percentage points in non-bank financials. Conversely, positions in food & beverage and auto sectors were cut by 2.1 percentage points and 0.9 percentage points respectively [2][3]. 2. **Southbound Net Inflows**: Southbound net inflows reached RMB 273.9 billion, marking a 25% year-over-year increase. The financial sector saw the largest inflows, followed by consumer discretionary and healthcare sectors [4][52]. 3. **National Team's ETF Purchases**: The "national team" is estimated to have added over RMB 200 billion in A-share ETFs in Q225, with 65% allocated to CSI 300 Index ETFs. This action is seen as a measure to stabilize the capital market [5][15]. 4. **New MF Issuance Trends**: New issuance of actively managed mutual funds totaled 59.9 billion units in Q225, a 128% increase year-over-year, but a 73% decline from the peak in 2020-21. The performance of these funds is expected to improve with better market conditions [3][4]. 5. **Consumer Sector Dynamics**: The report highlights a shift in investor preference towards "new consumption" and innovative drugs, indicating a potential growth area for mutual funds [4][5]. Additional Important Insights 1. **Geopolitical Uncertainty**: Elevated geopolitical risks have led to a preference for defensive sectors, including national defense, which ranked fourth in MF position increases [2][4]. 2. **A/H Premium Trends**: The A/H premium has decreased significantly due to liquidity differences between A-shares and H-shares, suggesting a potential medium-term low for this premium [4][5]. 3. **Performance Evaluation Mechanism**: The new performance evaluation mechanism for mutual funds may reshape market dynamics, potentially leading to increased inflows as market performance improves [3][4]. 4. **Risks to Market Stability**: Risks facing China's equities include a hard landing in the property market and slow structural reforms, which could lead to market shocks if not adequately addressed [62]. This summary encapsulates the key points discussed in the conference call, providing insights into the mutual fund sector's performance, investor behavior, and market dynamics in China.

Market Overview - Pre-market futures are mixed but showing signs of weakening, following record high closes on the S&P 500, with profit-taking being a potential factor [1] - The tech-heavy Nasdaq is up by 42 points (+0.18%), while the Dow is down by 300 points (-0.67%) due to UnitedHealth's DOJ probe [2] Job Market Data - Initial Jobless Claims decreased to 217K, marking the lowest level in 14 weeks and the sixth consecutive week of decline [3] - Continuing Claims are reported at 1.955 million, slightly above the previous week's revised figure, indicating a stall just below 2 million [4] Q2 Earnings Reports - American Airlines (AAL) reported earnings of 95 cents per share, exceeding expectations by +20.25%, but shares fell -6% due to warnings of softer demand [5] - Honeywell (HON) surpassed earnings expectations with $2.75 per share, a +4.2% increase from the previous year, but shares are down -2.7% as the company plans to split into three segments [6] - Union Pacific (UNP) reported earnings of $3.03 per share, beating expectations by +4.84%, with revenues of $6.2 billion also exceeding forecasts, though shares are down -3% [7] Economic Indicators - S&P flash Services PMI for July is expected to rise to 53.2, while Manufacturing PMI is anticipated to dip to 52.7, both remaining above the growth threshold of 50 [8][9] - New Home Sales for June are projected at 645K units, an increase from 623K in the previous month, despite disappointing Existing Home Sales figures [10] Upcoming Earnings Reports - Intel and Deckers Outdoor are scheduled to report their Q2 earnings after the market closes today [11]

UnitedHealth Group is responding to criminal and civil requests from the US Department of Justice about its Medicare practices, the company said, confirming reports of probes that surfaced over the last two years https://t.co/c8EbITweAE ...

Core Viewpoint - Centene Corporation (CNC) is expected to report a significant decline in earnings for Q2 2025, with an estimated earnings per share of 68 cents, reflecting a 71.9% decrease from the same quarter last year [1][6]. Earnings Estimates - The Zacks Consensus Estimate for revenues is projected at $43.9 billion, indicating a 10.3% growth compared to the previous year [2]. - The earnings estimate has not seen any upward revisions, with two downward movements in the past week [2]. Earnings Surprise History - Centene has beaten earnings estimates in three of the last four quarters, with an average surprise of 25.47% [3]. - The current Earnings ESP for Centene is 0.00%, and it holds a Zacks Rank of 5 (Strong Sell), suggesting a low probability of an earnings beat this time [4]. Factors Influencing Q2 Results - Premium revenues are expected to rise by 14% due to growth in the Commercial Marketplace business, with estimates for premiums at $39.9 billion, a 13.6% increase year-over-year [6][8]. - Medical costs are anticipated to surge by 17.8% year-over-year, which may negatively impact overall margins [6][12]. - Membership in the Commercial Marketplace is projected to grow by 22.7%, while Medicaid and Medicare memberships are expected to decline by 1.9% and 9.8%, respectively [9]. Revenue and Cost Projections - Service revenues are estimated at $774 million, reflecting a 7.1% decline from the previous year [10]. - The health benefits ratio (HBR) is expected to increase to 91%, indicating a deterioration of 300 basis points year-over-year [11].

Healthcare & Emotional Intelligence - The healthcare industry utilizes emotional intelligence and technology, such as virtual reality mirrors integrated with physiological parameters (heart rate, blood pressure, oxygen saturation, carbon dioxide output), to understand and address patients' unspoken pain, especially in unconscious patients [3][5][6] - The medical field employs techniques like mirror neuron mindfulness to sync with patients' fears in high-pressure environments like operating rooms [3] - The healthcare sector uses patient wall mirrors with cameras in waiting rooms to observe patients and learn about their complaints before consultations [10][11] Personal & Professional Challenges in Healthcare - Healthcare professionals may face discrimination and isolation due to illnesses like COVID-19 and tuberculosis, leading to social avoidance and professional neglect, even after becoming non-infectious [12][13][14][15][16] - The speaker experienced professional setbacks and personal pain, including discrimination due to health conditions, highlighting the societal biases and insecurities that cloud perceptions [12][13][14][15][16][20] Overcoming Obstacles & Achieving Goals - The speaker overcame initial failures in post-graduation entrance exams, securing 25 marks (unspecified total marks), and later succeeded in anesthesiology at Aliger Muslim University in her 40s, competing with students in their 20s [24][27] - The speaker self-published six books that became bestsellers, demonstrating resilience and determination to pursue writing aspirations despite time constraints and work responsibilities [29][30] - The speaker realized her dream of reaching the TEDx stage, marking a significant achievement after endeavoring towards it [30] Self-Perception & Personal Growth - Individuals often find their image unacceptable when looking in the mirror, experiencing feelings of inadequacy, which is considered normal [9] - Revisiting past memories can serve as a launchpad for personal improvement and rewriting one's narrative [21] - The speaker encourages individuals to identify their "mirror lies" through journaling and to question their self-perception, urging them to switch their lens [31]

Core Insights - Tenet Healthcare Corporation (THC) reported strong second-quarter 2025 results with adjusted earnings per share (EPS) of $4.02, exceeding estimates by 41.6% and showing a year-over-year increase of 74% [1][10] - Net operating revenues rose 3.2% year over year to $5.3 billion, surpassing consensus estimates by 2.4% [1][10] Financial Performance - Adjusted net income for the quarter was $369 million, a 63.3% increase year over year [3] - Adjusted EBITDA improved 18.6% year over year to $1.1 billion, exceeding estimates [3] - Adjusted EBITDA margin increased by 280 basis points to 21.3% [3] Segment Performance - Hospital Operations and Services segment generated net operating revenues of $4 billion, a 0.9% year-over-year increase, beating estimates [5] - Ambulatory Care segment saw net operating revenues rise 11.3% year over year to $1.3 billion, also exceeding estimates [7] Cost and Expenses - Total operating costs increased 2.3% year over year to $4.5 billion, primarily due to higher supplies expenses [4] Cash Flow and Financial Position - Cash and cash equivalents stood at $2.6 billion, down 13.1% from the end of 2024 [9] - Net cash from operations for the first half of 2025 was $1.8 billion, a 31.4% increase year over year [12] Share Repurchase and Guidance - THC repurchased shares worth $747 million in Q2 2025 and increased the share repurchase program by $1.5 billion [13] - The company raised its 2025 adjusted EPS guidance to $15.55-$16.21, indicating a 33.7% rise from the previous year [18]